Corentec Co., Ltd. completed the acquisition of 80% stake in Woosung Pharmaceutical Co., Ltd.
May 10, 2023
Share
Corentec Co., Ltd. (KOSDAQ:A104540) agreed to acquire 80% stake in Woosung Pharmaceutical Co., Ltd. for KRW 7.2 billion on May 9, 2023. Corentec will acquire 2.34 million shares in Woosung Pharma. The consideration will be paid in Cash. Transaction is expected to close on May 12, 2023.
Corentec Co., Ltd. (KOSDAQ:A104540) completed the acquisition of 80% stake in Woosung Pharmaceutical Co., Ltd. on May 10, 2023.
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.